TGFB1 and cancer: To enhance neoantigen detection, cancer cells were treated to amplify antigen expression using a cocktail of drugs that variously activate protein synthesis, block TGF-β signaling, block caspase activity, promote DNA demethylation, and suppress tolerogenic pathways.